RETRACTED: Effects of Oxymatrine on the Proliferation and Apoptosis of Human Hepatoma Carcinoma (Cells Technology in Cancer Research & Treatment, (2016), 15, 3, (487-497), 10.1177/1533034615587616);Effects of Oxymatrine on the Proliferation and Apoptosis of Human Hepatoma Carcinoma Cells

Technology in Cancer Research and Treatment

Volumn 15, Issue 3, 2016, Pages 487-497

  Liu, Yan ^a   Bi, Tingting ^a   Dai, Wei ^a   Wang, Gang ^a   Qian, Liqiang ^a   Gao, Quangen ^a   Shen, Genhai ^a  

^a First Hospital of Wujiang City   (China)

Author keywords

apoptosis; Bax Bcl 2; caspase; human hepatoma cells; oxymatrine

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CASPASE 3; FLUORESCEIN ISOTHIOCYANATE; FLUOROURACIL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; OXYMATRINE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL VIABILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFICACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; METHYL THIAZOLYL TETRAZOLIUM ASSAY; MOUSE; MTT ASSAY; MULTIPLE CYCLE TREATMENT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH INHIBITION RATE; WESTERN BLOTTING;

EID: 84966601933     PISSN: 15330346     EISSN: 15330338     Source Type: Journal    
DOI: 10.1177/1533034617722423     Document Type: Erratum

References (34)

1. S.Waly RaphaelZ.YangdeC.Yuxiang. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol. 2012;2012:421673.
2. M.Kojiro. Histopathology of liver cancers. Best Pract Res Clin Gastroenterol. 2005;19(1):39–62.
3. R.DhanasekaranA.LimayeR.Cabrera. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepatic Med. 2012;4:19–37.
4. S.F.AltekruseK.A.McGlynnM.E.Reichman. Hepatocellular carcinoma incidence, mortality, and survival trends in the united states from 1975 to 2005. J Clin Oncol. 2009;27(9):1485–1491.
5. J.D.YangL.R.Roberts. Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin North Am. 2010;24(4):899–919, viii.
6. G.SongQ.LuoJ.QinL.WangY.ShiC.Sun. Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells. Colloids Surf B Biointerfaces. 2006;48(1):1–5.
7. P.Stefaniuk. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2010;16(4):418–424.
8. Y.LiB.WangC.ZhouY.Bi. Matrine induces apoptosis in angiotensin II-stimulated hyperplasia of cardiac fibroblasts: effects on bcl-2/bax expression and caspase-3 activation. Basic Clin Pharmacol Toxicol. 2007;101(1):1–8.
9. M.SaleemI.MurtazaR.S.Tarapore. Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis. 2007;30(5):808–817.
10. J.R.GuzmanJ.S.KooJ.R.GoldsmithM.MühlbauerA.NarulaC.Jobin. Oxymatrine prevents nf-kappab nuclear translocation and ameliorates acute intestinal inflammation. Sci Rep. 2013;3:1629.
11. Y.G.CaoS.JingL.Li. Antiarrhythmic effects and ionic mechanisms of oxymatrine from Sophora flavescens. Phytother Res. 2010;24(12):1844–1849.
12. Z.Y.DengJ.LiY.JinX.L.ChenX.W.Lu. Effect of oxymatrine on the p38 mitogen-activated protein kinases signalling pathway in rats with ccl4 induced hepatic fibrosis. Chin Med J (Engl). 2009;122(12):1449–1454.
13. X.CuiY.WangN.KokudoD.FangW.Tang. Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Biosci Trends. 2010;4(2):39–47.
14. X.XiangG.WangX.CaiY.Li. Effect of oxymatrine on murine fulminant hepatitis and hepatocyte apoptosis. Chin Med J (Engl). 2002;115(4):593–596.
15. H.FanL.LiX.Zhang. Oxymatrine downregulates tlr4, tlr2, myd88, and nf-kappab and protects rat brains against focal ischemia. Mediat Inflamm2009;2009:704–706.
16. H.ChenJ.ZhangJ.Luo. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the nf-kappab-mediated vegf signaling pathway. Oncol Rep. 2013;30(2):589–595.
17. M.Q.SongJ.S.ZhuJ.L.Chen. Synergistic effect of oxymatrine and angiogenesis inhibitor nm-3 on modulating apoptosis in human gastric cancer cells. World J Gastroenterol. 2007;13(12):1788–1793.
18. Y.ZhangB.PiaoY.Zhang. Oxymatrine diminishes the side population and inhibits the expression of beta-catenin in mcf-7 breast cancer cells. Med Oncol. 2011;28(suppl 1):S99–S107.
19. Y.ZhangH.ZhangP.Yu. Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology. 2009;59(3):191–200.
20. Y.ZhangS.SunJ.Chen. Oxymatrine induces mitochondria dependent apoptosis in human osteosarcoma mnng/hos cells through inhibition of pi3k/akt pathway. Tumor Biol. 2014;35(2):1619–1625.
21. J.LiuY.YaoH.DingR.Chen. Oxymatrine triggers apoptosis by regulating bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia hl-60 cells. Tumor Biol. 2014;35(6):5409–5415.
22. Q.LingX.XuX.Wei. Oxymatrine induces human pancreatic cancer panc-1 cells apoptosis via regulating expression of bcl-2 and iap families, and releasing of cytochrome c. J Exp Clin Canc Res. 2011;30:66.
23. Y.JinJ.HuQ.WangZ.LiY.Chen. Effects of oxymatrine on the apoptosis of human esophageal carcinoma eca109 cell line and its mechanism. J Huazhong Univ Sci Technolog Med Sci. 2008;28(3):314–316.
24. B.BuendiaA.Santa-MariaJ.C.Courvalin. Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis. J Cell Sci. 1999;112(pt 11):1743–1753.
25. C.Z.LiangJ.K.ZhangZ.ShiB.LiuC.Q.ShenH.M.Tao. Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of bax and fas/fasl and downregulation of bcl-2. Cancer Chemother Pharmacol. 2012;69(2):317–331.
26. J.H.KimY.W.ChoiC.Park. Apoptosis induction of human leukemia u937 cells by gomisin n, a dibenzocyclooctadiene lignan, isolated from schizandra chinensis baill. Food Chem Toxicol. 2010;48(3):807–813.
27. P.N.KellyA.Strasser. The role of bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ. 2011;18(9):1414–1424.
28. A.StrasserS.CoryJ.M.Adams. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J. 2011;30(18):3667–3683.
29. S.L.SpencerP.K.Sorger. Measuring and modeling apoptosis in single cells. Cell. 2011;144(6):926–939.
30. A.Burlacu. Regulation of apoptosis by bcl-2 family proteins. J Cell Mol Med. 2003;7(3):249–257.
31. T.G.Cotter. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer. 2009;9(7):501–507.
32. X.S.WuT.YangJ.Gu. Effects of oxymatrine on the apoptosis and proliferation of gallbladder cancer cells. Anticancer Drug. 2014;25(9):1007–1015.
33. Z.ZhangX.WangW.Wu. Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytother Res. 2012;26(6):932–937.
34. S.Y.ParkS.J.ChoH.C.KwonK.R.LeeD.K.RheeS.Pyo. Caspase-independent cell death by allicin in human epithelial carcinoma cells: involvement of PKA. Cancer Lett. 2005;224(1):123–132.